Alli is the U.S. over-the-counter brand of orlistat 60 mg, a capsule used as a weight-loss aid in overweight adults aged 18 or older alongside a reduced-calorie, low-fat eating plan. Orlistat works locally in the gastrointestinal tract by inhibiting enzymes involved in digesting dietary fat. The Alli brand is an OTC product, but OTC does not mean suitable for everyone or interchangeable with every other weight-management treatment. The product's Drug Facts label, safety warnings and instructions must be read before deciding whether to use it.
On a U.S. retail listing, the Alli name should be paired with orlistat 60 mg, the capsule count, and the complete OTC Drug Facts information. Brand identity matters because a generic search result for “orlistat” could describe a different strength, an overseas product or an unrelated supplement. For an explanation of the 60 mg strength itself, see the orlistat 60 mg guide; for how the two U.S. brands differ in labeling and access, see Alli versus Xenical.
OrliLab is an independent educational and affiliate-supported information resource, not a prescribing service or pharmacy. We do not display verified live stock or dispense medicine. Consumers ready to compare retailers can use the Alli buying-options guide to check sellers, packages and checkout terms; product authenticity and suitability must still be assessed before purchase.
Alli is the consumer brand for oral orlistat capsules containing 60 mg of active ingredient per sealed capsule. The branded product is labeled as a weight-loss aid to be used with reduced-calorie, low-fat diet and physical activity. Its OTC classification permits purchase without an individual prescription by adults who meet the label's requirements, but it does not replace consultation with a clinician if personal health conditions, other medicines or unresolved safety questions are present.
A brand name alone does not identify every product characteristic. A shopper should confirm the active ingredient, strength, dosage form, intended route and complete Drug Facts label on the particular package, especially when a product listing uses generic language such as “fat blocker.” Do not confuse Alli with unverified herbal supplements or with similarly worded overseas or veterinary products.
For OTC products, the Drug Facts panel is more useful than a marketplace headline. Check “Active ingredient” for orlistat 60 mg, “Purpose” for the weight-loss-aid classification, “Uses” for the eligible population, and the warnings and directions. Also review inactive ingredients when allergy concerns exist. The labeled product information takes priority over promotional descriptions, user reviews or an AI-generated retailer summary.
Retail photographs may show outdated packaging, different counts or incomplete warning text. Before purchase, compare the currently displayed package label with the retailer's item and examine the physical seal when received. FDA's June 2026 action strengthened the OTC kidney-stone and kidney-injury warning; consumers should not rely on an older photo that omits it. The kidney-risk guide provides the wider safety context.
| Label field | What it tells you | Consumer check |
|---|---|---|
| Active ingredient | Orlistat 60 mg per capsule | Not 120 mg or an unidentified blend |
| Purpose and use | OTC weight-loss aid for overweight adults 18+ | Compare with the product’s complete instructions |
| Warnings | Contraindications, interactions and precaution statements | Read current kidney, pregnancy and medication warnings |
| Package information | Count, lot/expiry, retailer details and seal | Confirm legitimate, intact product before use |
Alli is labeled for weight loss in overweight adults at least 18 years old as part of a reduced-calorie, low-fat plan. The package uses eligibility guidance that should be considered in context rather than treated as a diagnosis. It should not be used merely because an OTC product is available, nor as a short-cut around identifying whether weight-management medication is appropriate. The exact current package instructions govern use, and clinicians can help address uncertainty.
The Drug Facts label distinguishes circumstances in which Alli must not be used from situations requiring professional advice. Its “do not use” warnings include a history of organ transplantation, cyclosporine use, diagnosed problems absorbing food, and use by someone who is not overweight; the label also says not to use it during pregnancy or breastfeeding. A history of kidney disease or kidney stones, gallbladder problems or pancreatitis calls for asking a doctor before use. Other medicines may warrant a doctor or pharmacist review. See orlistat contraindications for the full distinctions.
Alli, Xenical and relevant prescription generic products share the active ingredient orlistat, but they do not share the same access category or package labeling. Alli is a 60 mg nonprescription brand; Xenical is a 120 mg prescription brand; generic products require checking their specific strength, application and dispensing status. Being higher strength does not automatically make a product appropriate for the same person or justify substitution.
The most useful comparison starts with the product as labeled, not with a claim that one capsule is simply “twice as strong.” Eligibility, labeling, professional review, indications and dispensing requirements differ. For the clinical and regulatory comparison, use the dedicated brand comparison; for the numerical strengths and what they do and do not imply, use the 120 mg versus 60 mg guide.
The U.S. Alli labeling includes a 60-capsule Starter Pack; other retailer listings may contain different capsule counts or bundled materials. Sixty capsules in a carton means 60 individual capsules, each containing 60 mg of orlistat—it does not mean a different strength. Check the printed count, package type and the current offer, rather than inferring value or duration from a marketing image. Retail listings should be confirmed against the actual package before payment.
At the point of purchase, use a recognized retail pharmacy or responsible OTC seller, inspect the tamper-evident features and check the expiration date. A marketplace seller's promotional badge is not the same as confirming the product source and package integrity. Our online-safety checks cover misleading listings and counterfeit warning signs rather than ordinary Alli product characteristics.
Orlistat inhibits gastrointestinal lipases, reducing digestion and absorption of some dietary fat. It does not work by raising metabolism, removing fat already stored in the body or acting as a systemic appetite suppressant. Diet composition is central to the product's effect and to many of its gastrointestinal adverse effects. Changes in bowel habits can occur because some fat passes through the digestive tract unabsorbed.
A product description stating that Alli “blocks fat” can be broadly true but misleading without qualification. It blocks a portion of fat absorption, not all fat or every calorie. A reduced-calorie, low-fat eating plan remains part of its labeled use. The detailed biology belongs to how orlistat works, rather than this brand-identification page.
The Alli Drug Facts label contains meal-related directions and a daily maximum, along with instructions for reading the enclosed materials. Rather than changing the regimen based on a retailer's review or assuming that other orlistat strengths follow OTC directions, follow the actual packaging and discuss unanswered questions with a pharmacist or clinician. This page identifies where the instructions appear; our label-based dosing overview explains how to read them in context.
Alli is not intended to be used independently of dietary changes. The label recommends a balanced, reduced-calorie, low-fat diet; high-fat meals may make gastrointestinal effects more troublesome. Fat-soluble vitamin absorption can also be reduced, which is why the label discusses a daily multivitamin. See food interactions and vitamin considerations for focused detail.
Because Alli is OTC, some buyers may underestimate the significance of interactions or underlying conditions. Its label highlights medicines and health histories that require avoidance or professional consultation. Oily spotting, loose stools and bowel urgency are recognized possible adverse effects; persistent or alarming symptoms should not be dismissed as merely an inconvenience. Anyone concerned about personal suitability should seek medical advice before using the product.
The June 2026 FDA labeling update emphasizes rare kidney injury and kidney stones with orlistat products and specifically advises professional consultation for a history of kidney disease or stones. This is not a reason to speculate about an individual's likelihood of harm, but it is a reason to read the current warnings. Detailed assessments are on orlistat side effects and drug interactions.
Alli costs can vary by package count, retailer pricing, sales tax, shipping, loyalty discounts and available promotions. The most useful evergreen comparison is between equivalent product quantities and total checkout costs rather than a single number printed in an article. Listings sometimes show different package counts at similar prices, making quick headline comparisons unreliable.
OTC products may be treated differently from prescription medicines for insurance or savings programs; eligibility depends on the actual plan or program. OrliLab does not publish undated claims of a lowest price or exclusive pharmacy deal. The Alli pricing guide covers comparison methodology, while the brand page establishes what item you should be pricing.
Alli has a different mechanism and access pathway from prescription anti-obesity medicines such as GLP-1-based treatments. Brand popularity is not evidence that one therapy is suitable for a particular person. Labeled indications, clinical assessment, administration method, interactions, cost and follow-up requirements all matter in comparing approaches.
People uncertain between orlistat products and a prescription alternative can start with orlistat versus Wegovy or orlistat versus Zepbound. These pages examine treatment differences; this Alli page intentionally does not reproduce medication-by-medication comparisons.
Verify that the actual item is orlistat 60 mg, labeled for U.S. OTC use; read eligibility and warnings; and check medication interactions and the seller's identity. Then compare package count, seal, expiry and total cost. Keep product selection separate from medical suitability: a real branded carton can still be inappropriate for some people, and an OTC listing does not establish safety for a specific user.
A shopper comparing products can first verify the branded Alli 60 mg package, then read its Drug Facts and check whether any warning rules out use or calls for professional advice. Only after those steps should package count, fulfillment channel and total cost influence a purchasing decision. If the comparison involves prescription orlistat, confirm the different label and prescription requirement rather than treating the products as retail substitutes.
Alli is a U.S. brand of the active ingredient orlistat. Alli capsules contain 60 mg orlistat and are marketed over the counter for eligible adults.
No. Alli 60 mg is available as an OTC product under its Drug Facts labeling. OTC status does not mean that the medicine is appropriate for every person.
No. Both contain orlistat, but Alli is a 60 mg OTC brand and Xenical is a 120 mg prescription brand with different labeling and prescribing requirements.
Alli is labeled as a weight-loss aid for overweight adults aged 18 and older when used with a reduced-calorie, low-fat diet. The full Drug Facts label contains additional eligibility and safety information.
Rare kidney injury and kidney stones have been reported with orlistat products. FDA strengthened Alli labeling in June 2026; people with a history of kidney disease or stones should ask a clinician before use.
Check the Alli name and orlistat 60 mg in the Drug Facts panel, the printed capsule count and expiration date, and the tamper-evident package features. The U.S. label describes seals on the carton and bottle; do not use a package with damaged or missing protective features.
Alli is labeled for use alongside a reduced-calorie, low-fat diet and physical activity. It does not block all dietary fat or replace changes in eating habits.
No. Orlistat inhibits digestive lipases and reduces absorption of some dietary fat. It is not a stimulant appetite suppressant.
Not necessarily. Total costs depend on product, pack size, retailer, prescription coverage and other factors. Compare like-for-like quantities rather than assuming the OTC option is cheaper.
Yes. Safety warnings and packaging can be updated. Consult the current Drug Facts label rather than relying solely on an older image or article.